he drug lasmiditan, which is used to treat migraines, shows promise as a possible treatment for acute kidney injury, according to a new study from the University of Arizona. The findings are published ahead of print in the American Journal of Physiology–R

The article "Lasmiditan promotes recovery from acute kidney injury through induction of mitochondrial biogenesis” was highlighted by the American Journal of Physiology-Renal Physiology as an APSselect article for February.

The annual event exploring groundbreaking approaches in drug discovery is making an in-person return to Phoenix in September.

The American Association of Colleges of Pharmacy ranked the R. Ken Coit College of Pharmacy fifth in the nation by National Institutes of Health funding based on grants awarded to principal investigators in U.S. colleges and schools of pharmacy.

Dr. Rick Schnellmann, dean of the R. Ken Coit College of Pharmacy, received the 2022 Robert W. Berliner Award for Excellence in Renal Physiology from the American Physiological Society (APS).

Match Day 2022 has shown medical students where they will continue their education, including 2 UArizona Pharmacy students that are engaged, but matched in different states.

The BIO5 Postdoctoral Fellowship grants financial support and facilitates mentorship to enrich awardees’ research aims and career development.

Dr. Kristian Doyle leads a team at UArizona to study the connection between resulting inflammation after stroke, and the development of dementia. the inflammatory response at the site of the stroke which may be causing the condition.

The risk of developing dementia after a stroke may be reduced by a drug that could help immune cells process stroke-generated, cholesterol-rich brain debris.

From the vaccine to Alzheimer's, BIO5 members were part of the biggest Health Sciences Connect stories of 2021.

UArizona R. Ken Coit College of Pharmacy researchers hopes to increase medication adherence through culturally tailored education and other interventions.

The late John A. "Andy" Ware, who credited his pharmacy education for his success, bequeathed a significant gift to his alma mater.

Entrepreneur and University of Arizona College of Pharmacy alumnus R. Ken Coit has committed $50 million through his family foundation to solidify UArizona's place as a leader in pharmaceutical education, research, and innovation.

Tech Launch Arizona has kicked off a new UArizona program to recognize inventors who are named on issued patents

The third annual Drug Discovery and Development Summit aims to foster private-public collaboration and commercialization of new discoveries against diseases most burdensome to Arizonans.

A once-in-a-lifetime health care crisis, the COVID-19 pandemic has forced unprecedented changes – both temporary and lasting – in how governments, businesses, health care systems and educational institutions function as a result.